Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Futura Medical adds consumer healthcare products veteran to board

Jeff Needham was at Perrigo, the US-based manufacturer and marketer of consumer healthcare products, for 36 years

Futura Medical PLC (AIM:FUM) appointed consumer healthcare products veteran Jeff Needham to the board as a non-executive director.

The pharmaceutical company said Needham brings a wealth of knowledge and experience to the board having been at Perrigo Company (NYSE:PRGO) PLC, the US-based manufacturer and marketer of consumer healthcare products, for 36 years, and a board director of the Consumer Healthcare Products Association for 12 years.

While at Perrigo, Needham was responsible for the consumer self-care businesses in the Americas. His focus was on the development and long-term strategic direction of the business, including marketing, sales, new product pipeline development, business development and scientific affairs.

"We are delighted to welcome Jeff, a seasoned and highly respected industry leader, to the board of directors. His unparalleled management, strategic and corporate expertise, especially in Consumer Health, OTC [over the counter] and the USA underscores our ambition and focus on building a global brand to deliver MED3000, our breakthrough treatment for erectile dysfunction to sufferers as a therapy option without the need for a doctor's prescription,” said James Barder, the chief executive officer of Futura.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK